©2016 BY FRANCOLAW, PLLC. All Rights Reserved.

CONTACT US | LEGAL NOTICE | DESIGN BY DORSA WEB DESIGNS

The information on this website is for general information purposes only. Nothing on this site should be taken as legal advice for any individual case or situation. This information is not intended to create, and receipt or viewing does not constitute an attorney-client relationship.

FrancoLaw, PLLC

500 W. 2nd Street

Floor 19, Suite 138

Austin, TX 78701

NEWS & CASE UPDATES

July 19, 2019

March 2019 - A $775 million dollar settlement was announced by Bayer and Janssen Pharmaceuticals, a division of Johnson & Johnson. The deal will settle about 25,000 lawsuits alleging Xarelto caused internal bleeding risks and the manufacturer failed to warn about the r...

August 18, 2017

XARELTO LITIGATION

(Dora Mingo vs. Janssen Research & Development, LLC et al., Case No. 2:15-cv-03469)

This is the third trial verdict for defense in the Xarelto MDL 2592 bellwether trials, the verdict was returned in favor of the defendants not long after after closing...

June 12, 2017

XARELTO LITIGATION

On June 12, 2017, a New Orleans federal jury awarded a defense verdict to Bayer and Janssen in the second bellwether trial in 15,000-case litigation over severe health complications allegedly caused by their drug Xarelto. This is the second time the d...

May 31, 2017

XARELTO LITIGATION

The Xarelto case is pursing rapidly. Unfortunately, the first Federal Court trial was won by the Defendants. There are three more trials scheduled in Federal Court in New Orleans. After these trials are over, the Xarelto trials will begin in Philadelp...

January 27, 2017

A multi-district litigation in Louisiana currently holds over 14,000 Xarelto lawsuits filed against Johnson & Johnson and its subsidiary, Janssen Pharmaceuticals. This figure does not include another 1,000 lawsuits that are currently pending in a mass tort program in P...

Please reload

SEARCH FOR YOUR CASE